What You Ought to Know:
- The Knowledge Supply: Sage Growth Partners launched its “Health IT Purchasing Forecast 2026-2027: Where C-Suites are Investing Amid Declining Capital Budgets” report, primarily based on a benchmark survey of 101 hospital and well being system C-suite executives.
- The Funds Squeeze: A big 41% of C-suite leaders anticipate their capital investments shall be lowered over the following two years. Solely 5% count on a rise of 20% or extra, representing a notable decline from prior years.
- The Progress Pivot: Regardless of shrinking budgets, executives are prioritizing revenue-generating know-how. 46% of respondents say funding for brand spanking new markets or income streams is a excessive precedence (up from 34% in 2023), and 40% are explicitly prioritizing affected person acquisition.
- The AI Explosion: Synthetic intelligence has formally overtaken EMR optimization as a high precedence. 57% of C-suites rank AI-based medical options as their high know-how initiative for the following two years—a large bounce from 19% in 2023. Moreover, 29% rank AI administrative options of their high 5, up from simply 6% in 2023.
- The ROI Mandate: Distributors should take word: 77% of executives charge anticipated ROI as probably the most crucial issue of their health IT buying selections, up from 50% in 2023. Much more aggressively, 39% now explicitly demand a 2x-3x return on their investments.
The C-Suite Squeeze: Why Hospital IT Budgets Are Shrinking Whereas AI Spending Soars
In response to the newly launched Health IT Purchasing Forecast 2026-2027 from Sage Growth Partners, 41% of surveyed C-suite leaders anticipate their capital investments shall be lowered over the following two years. But, paradoxically, these similar executives are aggressively funding top-line progress initiatives and radically accelerating their adoption of synthetic intelligence.
For years, the undisputed king of the IT funds was Electronic Medical Record (EMR) optimization. Not anymore. The survey reveals {that a} staggering 57% of C-suites now rank AI-based medical options as their high know-how initiative, skyrocketing from simply 19% in 2023. Moreover, 29% rank AI-based administrative options of their high 5 initiatives, up from 6% in 2023.
How are hospitals affording this large AI pivot whereas concurrently bracing for a 41% discount in capital funding? By relentlessly scrutinizing ROI and shifting {dollars} away from conventional overhead.
“As well being methods and hospitals grapple with declining capital investments, C-suite leaders are more likely to apply better levels of scrutiny to well being IT buying selections,” famous Dan D’Orazio, CEO of Sage Progress Companions. “General, capital planning is shifting towards initiatives that drive progress, akin to buying and retaining sufferers, increasing into new markets, and diversifying income streams to extend high line income”.
The Demise of the “Good-to-Have”
When capital is reasonable, hospitals will experiment. When capital is tight, they solely purchase survival. In response to the report, 77% of respondents now charge “anticipated ROI” as probably the most crucial issue of their buying selections—up from 50% in 2023. Much more aggressively, 39% of executives demand a 2x-3x monetary return on their investments.
“In the end, C-suites wish to well being IT corporations to exhibit cost-savings to CFOs targeted on driving ROI, and to assist CIOs align digital methods with organizational efficiency and monetary objectives,” mentioned Stephanie Kovalick, Chief Technique Officer at Sage Progress Companions.
If an AI vendor can not definitively show how their software program captures a brand new affected person, unlocks a brand new income stream, or automates a expensive administrative bottleneck, their gross sales cycle will stall indefinitely. In 2026, know-how is not an operational luxurious; it’s the final lever for top-line survival.
Click on here to obtain a replica of the Well being IT Buying Forecast 2026-2027 report.
